Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...
Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, ...
The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Cancer experts say the new method could 'potentially offer another option in the future' ...
Pap smears and HPV tests can catch issues early—long before they become cancer. Learn why these simple screenings matter and how to make the experience more comfortable.
HPV causes about 36,000 cancer cases each year in the U.S.
Cervical cancer is one of the few types of cancers that is highly preventable and can also be cured when diagnosed at an early stage. However, it is detected late mainly because there's ignorance ...
Cervical cancer may be more common in people over 60 years old than originally believed. However, current screenings suggest that individuals over the age of 65 no longer receive regular cervical ...
HPV vaccination can prevent up to 90% of cervical cancer cases when implemented on a large scale, the Federation of Cancer Patients' Associations of Romania (FABC) said, while also emphasizing the ...
Anna Giuliano’s research on HPV infections and vaccines helped transform cervical cancer from a leading killer into a disease that the WHO now believes can be eliminated.
Early detection and accurate typing of cancer are critical for improving patient survival rates. While traditional pathology remains the gold ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results